Gastrointestinal (GI) Clinical Trial Program

ARGO Study: NSABP C-13
A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients with Stage III Colon Cancer.
Familial Colorectal Registry
Familial Colorectal Cancer Registry Program.

To access the full protocols, please contact:
Rita McTighe, Oncology Clinical Research Coordinator, at or call (732) 923-6564.